Dr.-Ing. Thomas Wucherpfennig

Boehringer Ingelheim Pharma GmbH & Co. KG
Bioprocess Development Biologicals

Binger Strasse 173

55216 Ingelheim am Rhein

Phone +49 7351 54-144806

Mail Dr. Thomas Wucherpfennig


Thomas pursued the study of Biotechnology at the Technical University of Braunschweig, Germany, and Chemical Engineering at the University of Waterloo, Canada. He earned his PhD in Bioprocess Engineering from the Technical University of Braunschweig. Prior to joining Boehringer Ingelheim as a postdoctoral fellow in 2014, Thomas acquired valuable experience in the industrial biotech sector at Roche and Clariant. Since 2015, he has held various roles in cell culture process development at Boehringer Ingelheim and currently serves as a Senior Principal Scientist, spearheading late-stage process development. In addition, Thomas is a lecturer at FH Oberösterreich in Wels and TUHH – Hamburg University of Technology, His research focus is on bioprocess scale-up, bioreactor characterization, Process Analytical Technology (PAT), and cell culture process modeling.

Research Interests

  • Scale-up of bioprocesses
  • Bioreactor characterization
  • Computational Fluid Dynamics (CFD)
  • Process Analytical Technology (PAT)
  • Cell culture process modelling

Publications

[185020]
Title: Enhancing functional expression of heterologous lipase in the periplasm of Escherichia coli.
Written by: Xu Y., Yasin A., Wucherpfennig T., Chou C.P.
in: <em>World J. Microb. Biot.</em>. (2008).
Volume: <strong>24</strong>. Number: (12),
on pages: 2827-2835
Chapter:
Editor:
Publisher:
Series:
Address:
Edition:
ISBN:
how published:
Organization:
School:
Institution:
Type:
DOI:
URL:
ARXIVID:
PMID:

Note:

Abstract: Functional expression of heterologous Pseudozyma antarctica lipase B (PalB) in the periplasm of Escherichia coli was explored using four fusion tags, i.e. DsbC, DsbA, maltose-binding protein (MBP), and FLAG in the sequence of increasing expression efficacy. Amongst these fusion tags, FLAG and MBP appear to be the most effective ones in terms of boosting enzyme activity and enhancing solubility of PalB, respectively. Overexpression of these PalB fusions often resulted in concomitant formation of insoluble inclusion bodies. Coexpression of a selection of periplasmic folding factors, including DegP (and its mutant variant of DegPS210A), FkpA, DsbA, DsbC, and a cocktail of SurA, FkpA, DsbA, and DsbC, could improve the expression performance. Coexpression of DsbA appeared to be the most effective in reducing the formation of inclusion bodies for all the four PalB fusions, implying that functional expression of PalB could be limited by initial bridging of disulfide bonds. Culture performance was optimized by overexpressing FLAG-PalB with DsbA coexpression, resulting in a high volumetric PalB activity of 360 U/L.